These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 8165521

  • 1. [The effect of the time interval between fractions on the result of a fractionated irradiation of the R1H tumor].
    Beck-Bornholdt HP, Kleineidam M, Pieconka A.
    Strahlenther Onkol; 1994 Apr; 170(4):232-4. PubMed ID: 8165521
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pentoxifylline enhances tumor oxygenation and radiosensitivity in rat rhabdomyosarcomas during continuous hyperfractionated irradiation.
    Zywietz F, Böhm L, Sagowski C, Kehrl W.
    Strahlenther Onkol; 2004 May; 180(5):306-14. PubMed ID: 15127161
    [Abstract] [Full Text] [Related]

  • 6. Radiotherapy of the rhabdomyosarcoma R1H of the rat: hyperfractionation--126 fractions applied within 6 weeks.
    Beck-Bornholdt HP, Maurer T, Becker S, Omniczynski M, Vogler H, Würschmidt F.
    Int J Radiat Oncol Biol Phys; 1989 Mar; 16(3):701-5. PubMed ID: 2921168
    [Abstract] [Full Text] [Related]

  • 7. Parameters affecting the response of experimental tumours to fractionated radiotherapy.
    Beck-Bornholdt HP.
    Strahlenther Onkol; 1988 Mar; 164(3):155-64. PubMed ID: 3281297
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Oxygenation of tumor recurrences following fractionated radiotherapy of primary tumors. Studies on the rhabdomyosarcoma R1H of the rat.
    Kehrl W, Sagowski C, Wenzel S, Zywietz F.
    Strahlenther Onkol; 2004 Jun; 180(6):383-90. PubMed ID: 15175874
    [Abstract] [Full Text] [Related]

  • 10. Combined modality treatment of the rhabdomyosarcoma R1H of the rat: tumor and normal tissue response after cisplatin and conventional or accelerated irradiation treatment.
    Würschmidt F, Beck-Bornholdt HP.
    Int J Radiat Oncol Biol Phys; 1995 May 15; 32(2):391-4. PubMed ID: 7751181
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Combined treatment of rat rhabdomyosarcoma R1H with mitomycin C and X-rays.
    Baisch H, von Stritzky B.
    Strahlenther Onkol; 1990 Jun 15; 166(6):430-4. PubMed ID: 2114041
    [Abstract] [Full Text] [Related]

  • 13. Five year results of a randomized trial comparing hyperfractionated to conventional radiotherapy over four weeks in locally advanced head and neck cancer.
    Cummings B, Keane T, Pintilie M, Warde P, Waldron J, Payne D, Liu FF, Bissett R, McLean M, Gullane P, O'Sullivan B.
    Radiother Oncol; 2007 Oct 15; 85(1):7-16. PubMed ID: 17920715
    [Abstract] [Full Text] [Related]

  • 14. Radiotherapy of the rhabdomyosarcoma R1H of the rat: recovery from radiation injury in tumour and skin.
    Würschmidt F, Becker S, Maurer T, Omniczynski M, Schelp R, Vogler H, Beck-Bornholdt HP.
    Radiother Oncol; 1992 Feb 15; 23(2):105-10. PubMed ID: 1546185
    [Abstract] [Full Text] [Related]

  • 15. Impact of tumor stroma on expression of the tumor bed effect in R1H rat rhabdomyosarcoma.
    Baumann M, Würschmidt F, Twardy A, Beck-Bornholdt HP.
    Radiat Res; 1994 Dec 15; 140(3):432-6. PubMed ID: 7526411
    [Abstract] [Full Text] [Related]

  • 16. Comparison of effects of daily versus hyperfractionated split-course radiation schedules with and without cyclophosphamide on median survival, metastatic dissemination, tumor cure, and growth rates.
    Looney WB, Hopkins HA, Longerbeam MB, Carter WH.
    Cancer Res; 1983 Jan 15; 43(1):60-7. PubMed ID: 6847784
    [Abstract] [Full Text] [Related]

  • 17. Influence of treatment time on the response of rat rhabdomyosarcoma R1H to fractionated irradiation.
    Beck-Bornholdt HP, Omniczynski M, Theis E, Vogler H, Würschmidt F.
    Acta Oncol; 1991 Jan 15; 30(1):57-63. PubMed ID: 2009185
    [Abstract] [Full Text] [Related]

  • 18. Ultrafractionation does not improve the results of radiotherapy in radioresistant murine DDL1 lymphoma.
    Krause M, Prager J, Wohlfarth J, Hessel F, Dorner D, Haase M, Joiner MC, Baumann M.
    Strahlenther Onkol; 2005 Aug 15; 181(8):540-4. PubMed ID: 16044223
    [Abstract] [Full Text] [Related]

  • 19. Influence of the timing of a concomitant boost during fractionated irradiation of rat rhabdomyosarcoma R1H.
    Dubben HH, Beck-Bornholdt HP.
    Acta Oncol; 1993 Aug 15; 32(1):79-82. PubMed ID: 8466769
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.